Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate vs dexmedetomidine for anesthesia recovery in one-lung ventilation
ChiCTR2300074617Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in lung neoplasm and None comparing Remimazolam tosylate group with Dexmedetomidine group (2 arms). Primary endpoints: Average arterial pressure, Heart rate and 3 more. Started Jul 2022; status: completed.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
lung neoplasm
Beyond the preview
Go deeper on ChiCTR2300074617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074617.